AlzeCure Pharma: Funding, Investors & Team (Sep 2026)
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and related neurodegenerative disorders. Conceptually, AlzeCure is an industry-standard incubator for novel projects. It comprises key professionals exhibiting complementary expertise from molecule to man.
AlzeCure Pharma has raised $3.3M across 1 funding round on record, the most recent an undisclosed round of $3.3M announced in Apr 2026.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
AlzeCure Pharma Company Profile and Key Stats
Latest funding round on record: Apr 2026.
AlzeCure Pharma Funding Rounds
AlzeCure Pharma Founders and Leadership Team
No contact details are on record for this team yet.
AlzeCure Pharma Funding Compared to Other Health Care Startups
AlzeCure Pharma's latest round of $3.3M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AlzeCure Pharma in Health Care and Stockholm
Companies Similar to AlzeCure Pharma
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
AlzeCure Pharma Funding FAQs
What does AlzeCure Pharma do?
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and related neurodegenerative disorders. Conceptually, AlzeCure is an industry-standard incubator for novel projects. It comprises key professionals exhibiting complementary expertise from molecule to man.
How much funding has AlzeCure Pharma raised?
AlzeCure Pharma has raised $3.3M across 1 round on record. The most recent is an undisclosed round of $3.3M announced in Apr 2026.
When did AlzeCure Pharma last raise funding?
AlzeCure Pharma's most recent funding round on record is an undisclosed round of $3.3M, announced in Apr 2026.
Who founded AlzeCure Pharma?
FundedIQ lists Martin Jonsson (Founder) at AlzeCure Pharma.
Where is AlzeCure Pharma headquartered?
AlzeCure Pharma is based in Stockholm, Stockholms Lan, Sweden.
How many employees does AlzeCure Pharma have?
AlzeCure Pharma is in the 11-50 employee band.
How does AlzeCure Pharma's funding compare to other Health Care startups?
AlzeCure Pharma's latest round of $3.3M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's AlzeCure Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AlzeCure Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.